Davide Prandi

Trento, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer.

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer.

Journal: The Journal of clinical investigation

Published: January 30, 2024

Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.

Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.

Journal: The Journal of pathology

Published: August 23, 2021

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.

Journal: The Journal of clinical investigation

Published: March 30, 2021

Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.

Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.

Journal: Cell systems

Published: January 28, 2021

Systematic Assessment of Tumor Purity and Its Clinical Implications.

Systematic Assessment of Tumor Purity and Its Clinical Implications.

Journal: JCO precision oncology

Published: June 18, 2020

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.

Journal: Nature communications

Published: February 08, 2020

Ploidy- and Purity-Adjusted Allele-Specific DNA Analysis Using CLONETv2.

Ploidy- and Purity-Adjusted Allele-Specific DNA Analysis Using CLONETv2.

Journal: Current protocols in bioinformatics

Published: September 17, 2019

Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues.

Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 08, 2019

Genomic correlates of clinical outcome in advanced prostate cancer.

Genomic correlates of clinical outcome in advanced prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 08, 2019

TPES: tumor purity estimation from SNVs.

TPES: tumor purity estimation from SNVs.

Journal: Bioinformatics (Oxford, England)

Published: January 11, 2019

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 18, 2018

Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.

Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.

Journal: JCO precision oncology

Published: January 16, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026